COVID-19 and MS
Watch the following expert videos to:
- Catch up on the MSVirtual2020 Biogen-sponsored Satellite Symposium ‘COVID-19 and MS: Lessons (to be) learned from the pandemic’
- Discover a wide range of perspectives on the lessons learned from the COVID-19 pandemic and the lessons we can still learn
MSVirtual2020 brought together neurologists from around the world for the 8th Joint ACTRIMS-ECTRIMS Meeting. Watch video footage from the Biogen Satellite Symposium ‘COVID-19 and MS: Lessons (to be) learned from the pandemic’ below, featuring relevant insights from Professors Burioni, Peeters and Montalban.
What happens when COVID-19 meets the flu season? A virologist perspective
To gain insight into the impact of the COVID-19 pandemic and its interaction with the upcoming flu season, watch these 3 videos with Professor Roberto Burioni.
The impact of the ongoing COVID-19 pandemic has inspired an enormous level of research into the novel and complex characteristics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Given its differences with other respiratory viruses, assumptions should be avoided.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
How did MS patients do with COVID-19? A data scientist perspective
Watch these 5 videos to find out how the MS Global Data Sharing Initiative is collecting data to help answer urgent questions around the management of MS with Professor Liesbet Peeters.
The analysis of ‘big data’ can provide insights for making better informed decisions. The following videos discuss how data from multiple global sources have been collected into an international database and now providing information on the outcomes for people with multiple sclerosis (MS) who have COVID-19.
COVID-19 and the MS Global Data Sharing Initiative
The mission of the MS Global Data Sharing Initiative is to provide answers to urgent questions related to the risk factors for SARS-CoV-2 infection in people with MS. The initiative was designed to scale up COVID-19 data collection, share insights on the effect of COVID-19, and stimulate ongoing research.
How does the Global Data Sharing Initiative work?
The Global Data Sharing Initiative identified a minimal data set common across many different registries and cohorts. The initiative also developed a platform and data sharing pipeline to bring together data from clinicians, people with MS, registries, and data cohorts from across the world.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Will COVID-19 change the way we manage MS? A neurologist perspective
To discover how the COVID-19 pandemic has changed how we manage multiple sclerosis (MS), watch the following 5 videos with Professor Xavier Montalban.
The COVID-19 pandemic has had a huge impact in countries around the world. Notably, it has required healthcare professionals to adapt and utilise new technologies to manage MS patients. It also led to many questions about MS treatment decision making. These changes may have long lasting effects. The following videos address the question, will COVID-19 change the way we manage MS forever?
The impact of COVID-19
The COVID-19 lockdown majorly impacted mobility patterns in Spain. Societal changes were evident in google reports and showed how striking the effects of the “stay at home” order in Spain were. COVID-19 also affected the healthcare system, individual MS patients and the treatment of MS.
Adapting to the COVID-19 pandemic
Adapting to COVID-19 required using digital communication at many levels. Telemedicine was instituted not only for individual patient consultations, but also for group rehabilitation and psychological support. Logistical changes at the Cemcat included home infusion of selected patients and DMT deliveries.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
of interest
are looking at
saved
next event
Developed by EPG Health for Medthority in partnership with Biogen.
Biogen-64187 July 2020. Biogen-81091 October 2020. Biogen-122916 September 2021.